We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare (HCA) Q3 Earnings Miss Estimates, Down Y/Y
Read MoreHide Full Article
HCA Healthcare, Inc.’s (HCA - Free Report) third-quarter 2020 adjusted earnings of $1.92 per share missed the Zacks Consensus Estimate by 28.6%. Further, the bottom line declined 13.9% year over year due to lower patient admissions and higher costs.
Quarterly Details
HCA Healthcare’s revenues of $13.3 billion beat the Zacks Consensus Estimate by 0.1%. The top line also improved 4.9% from the year-ago period.
Same facility equivalent admissions declined 9% year over year, while same facility admissions tumbled 3.8% year over year. However, same facility revenue per equivalent admission grew 14.8% year over year on account of higher acuity of patients treated and favorable payer mix witnessed in the third quarter.
Same facility inpatient surgeries and same facility outpatient surgeries slid 6.8% and 6.3%, respectively, year over year.
Salaries and benefits, supplies and other operating expenses inched up 0.6% year over year to $10.5 billion.
Adjusted EBITDA totaled $2.1 billion, down 10.2% year over year.
As of Sep 30, 2020, HCA Healthcare operated 187 hospitals.
HCA Healthcare, Inc. Price, Consensus and EPS Surprise
As of Sep 30, 2020, the company had cash and cash equivalents of $6.6 billion, comparing favorably from the 2019-end figure of $621 million. Total assets came in at $51.02 billion as of Sep 30, 2020, up 13.2% from 2019-end level.
Total debt of nearly $31 billion as of Sep 30, 2020 decreased 8.2% from 2019-end level.
In the reported quarter, capex came in at $489 million minus acquisitions.
Cash flows provided by operating activities were $2.7 billion, up 27.8% year over year.
Among other players from the medical space that have reported third-quarter earnings so far, the bottom-line results of UnitedHealth Group Incorporated (UNH - Free Report) and Tenet Healthcare Corporation (THC - Free Report) beat estimates.
Upcoming Q3 Release
Alexion Pharmaceuticals, Inc. has an Earnings ESP of +0.84% and a Zacks Rank #3. The company is scheduled to release third-quarter 2020 earnings on Oct 29.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.
Image: Bigstock
HCA Healthcare (HCA) Q3 Earnings Miss Estimates, Down Y/Y
HCA Healthcare, Inc.’s (HCA - Free Report) third-quarter 2020 adjusted earnings of $1.92 per share missed the Zacks Consensus Estimate by 28.6%. Further, the bottom line declined 13.9% year over year due to lower patient admissions and higher costs.
Quarterly Details
HCA Healthcare’s revenues of $13.3 billion beat the Zacks Consensus Estimate by 0.1%. The top line also improved 4.9% from the year-ago period.
Same facility equivalent admissions declined 9% year over year, while same facility admissions tumbled 3.8% year over year. However, same facility revenue per equivalent admission grew 14.8% year over year on account of higher acuity of patients treated and favorable payer mix witnessed in the third quarter.
Same facility inpatient surgeries and same facility outpatient surgeries slid 6.8% and 6.3%, respectively, year over year.
Salaries and benefits, supplies and other operating expenses inched up 0.6% year over year to $10.5 billion.
Adjusted EBITDA totaled $2.1 billion, down 10.2% year over year.
As of Sep 30, 2020, HCA Healthcare operated 187 hospitals.
HCA Healthcare, Inc. Price, Consensus and EPS Surprise
HCA Healthcare, Inc. price-consensus-eps-surprise-chart | HCA Healthcare, Inc. Quote
Financial Update
As of Sep 30, 2020, the company had cash and cash equivalents of $6.6 billion, comparing favorably from the 2019-end figure of $621 million. Total assets came in at $51.02 billion as of Sep 30, 2020, up 13.2% from 2019-end level.
Total debt of nearly $31 billion as of Sep 30, 2020 decreased 8.2% from 2019-end level.
In the reported quarter, capex came in at $489 million minus acquisitions.
Cash flows provided by operating activities were $2.7 billion, up 27.8% year over year.
Zacks Rank & Peer Releases
HCA Healthcare currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among other players from the medical space that have reported third-quarter earnings so far, the bottom-line results of UnitedHealth Group Incorporated (UNH - Free Report) and Tenet Healthcare Corporation (THC - Free Report) beat estimates.
Upcoming Q3 Release
Alexion Pharmaceuticals, Inc. has an Earnings ESP of +0.84% and a Zacks Rank #3. The company is scheduled to release third-quarter 2020 earnings on Oct 29.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.
Click here for the 6 trades >>